We serve Chemical Name:4-(Trifluoromethoxy)thiophenol CAS:169685-29-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(Trifluoromethoxy)thiophenol
CAS.NO:169685-29-4
Synonyms:Benzenethiol, 4-(trifluoromethoxy)-;4-(Trifluoromethoxy)thiophenol;MFCD00052312;4-(Trifluoromethoxy)benzenethiol;SHR DOXFFF;4-(Trifluoromethoxy)benzene-1-thiol
Molecular Formula:C7H5F3OS
Molecular Weight:194.174
HS Code:2930909090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:182.3±35.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.495
PSA:48.03000
Exact Mass:194.001312
LogP:3.50
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2810
Packing Group:III
Contact us for information like Benzenethiol, 4-(trifluoromethoxy)- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(Trifluoromethoxy)benzene-1-thiol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,SHR DOXFFF Use and application,4-(Trifluoromethoxy)benzene-1-thiol technical grade,usp/ep/jp grade.
Related News: ICIG is a privately owned industrial holding company focusing on mid-sized chemicals and pharmaceutical businesses. 4-(Trifluoromethoxy)thiophenol manufacturer Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business. 4-(Trifluoromethoxy)thiophenol supplier Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. 4-(Trifluoromethoxy)thiophenol vendor Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business. 4-(Trifluoromethoxy)thiophenol factory Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.
